Results 251 to 260 of about 547,226 (312)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Curative care expenditure across different comorbidity states of chronic hepatitis B: a prevalence study in Sichuan Province, China. [PDF]

BMJ Open
Qiaoying W, Lanming F, Yang L, Jia L, Qun S, Yuelin Z.   +5 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Orthodontic Visits According to Socioeconomic Status Among Children Living in the City of Kuopio, Finland: The PANIC Study. [PDF]

Clin Exp Dent Res
Viisanen M, Raittio E, Ikävalko T, Peltomäki T, Suominen AL, Tolonen V, Soininen S, Karvinen H, Lakka TA.   +8 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

CAR-T Access Disparities for Multiple Myeloma in the Midwest: A Social Determinants of Health Perspective. [PDF]

Curr Oncol
Weise M, Atrash S, Ansari B, Mushtaq MU, McGuirk J, Abdallah AO, Mahmoudjafari Z, Ahmed N.   +7 more
europepmc   +1 more source

Relevance and consequence of economic and social resources of severely ill persons and their informal caregivers at the end-of-life: a systematic review of qualitative studies. [PDF]

BMC Palliat Care
Matzinger M, Baum E, Bernhardsgrütter D, Kesseli M, Michelak G, Orosaj F, Kobleder A, Vetsch J.   +7 more
europepmc   +1 more source

Integration of social determinants of health in quality indicators for colorectal cancer surgery: a scoping review. [PDF]

EClinicalMedicine
Bondzi-Simpson A, Ribeiro T, Zhu A, Lofters A, Covelli A, Snyder RA, Clarke CN, Coburn NG, Hallet J.   +8 more
europepmc   +1 more source

Visit Characteristics Associated With Pediatric Dental Appointment No-Shows in an Academic Dental Setting. [PDF]

Int J Dent
de Oliveira RCG, Khalid H, Zhang Z, Chakraborty S, Benzano D, Kruger JS, McKernan SC.   +6 more
europepmc   +1 more source

Status of comprehensive geriatric assessment in hospital settings: a cross-sectional survey. [PDF]

Front Med (Lausanne)
Lyu H, Dong Y, Chen R, Zeng Y, Liu J, Song X, Wang H, Xing L, Zhang X, Wang Y.   +9 more
europepmc   +1 more source